Characterization of alginate/poly-L-lysine particles as antisense oligonucleotide carriers

被引:48
作者
Ferreiro, MG
Tillman, L
Hardee, G
Bodmeier, R
机构
[1] Free Univ Berlin, Coll Pharm, D-12169 Berlin, Germany
[2] ISIS Pharmaceut, Carlsbad, CA 92008 USA
关键词
alginate; antisense oligonucleotide; complexation; microparticles; nanoparticles; poly-L-lysine;
D O I
10.1016/S0378-5173(02)00030-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The gel forming characteristics of alginate in the presence of calcium ions and further crosslinking with poly-L-lysine led to the formation of sponge-like nano- and microparticles. The particle size was varied by adjusting the final concentrations of and proportions between the components. The region for particle formation was from 0.04 to 0.08% (w/v) of alginate in the final formulation, the change from the nm to pm size range occurred at a concentration of approx. 0.055% (w/v). Oligonucleotide-loaded microparticles were prepared by two different methods, either by absorption of the drug into the crosslinked polymeric matrix or by incorporation of an oligonucleotide/poly-L-lysine complex into a calcium alginate pre-gel. The release of oligonucleotide from microparticles prepared by the first method was higher. The addition of increasing amounts Of poly-L-lysine resulted in larger particles, higher oligonucleotide loading and slower drug release. An increase in the final solid content of the formulation led to larger particles, especially with high concentrated calcium alginate pre-gels. Microparticles based on alginate and poly-L-lysine are potential carriers for antisense oligonucleotides. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:47 / 59
页数:13
相关论文
共 34 条
[1]  
Agrawal S, 1998, HANDB EXP PHARM, V131, P525
[2]   The delivery of antisense therapeutics [J].
Akhtar, S ;
Hughes, MD ;
Khan, A ;
Bibby, M ;
Hussain, M ;
Nawaz, Q ;
Double, J ;
Sayyed, P .
ADVANCED DRUG DELIVERY REVIEWS, 2000, 44 (01) :3-21
[3]   Association and dissociation characteristics of polymer/DNA complexes used for gene delivery [J].
Arigita, C ;
Zuidam, NJ ;
Crommelin, DJA ;
Hennink, WE .
PHARMACEUTICAL RESEARCH, 1999, 16 (10) :1534-1541
[4]   Studies on diffusion in alginate gels .1. Effect of cross-linking with calcium or zinc ions on diffusion of acetaminophen [J].
Aslani, P ;
Kennedy, RA .
JOURNAL OF CONTROLLED RELEASE, 1996, 42 (01) :75-82
[5]   Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides [J].
Aynié, I ;
Vauthier, C ;
Chacun, H ;
Fattal, E ;
Couvreur, P .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1999, 9 (03) :301-312
[6]   Pharmacokinetics in mice of a [H-3]-labeled phosphorothioate oligonucleotide formulated in the presence and absence of a cationic lipid [J].
Bennett, CF ;
Zuckerman, JE ;
Kornbrust, D ;
Sasmor, H ;
Leeds, JM ;
Crooke, ST .
JOURNAL OF CONTROLLED RELEASE, 1996, 41 (1-2) :121-130
[7]   Oral vaccination with alginate microsphere systems [J].
Bowersock, TL ;
HogenEsch, H ;
Suckow, M ;
Porter, RE ;
Jackson, R ;
Park, H ;
Park, K .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) :209-220
[8]   Oral vaccination of animals with antigens encapsulated in alginate microspheres [J].
Bowersock, TL ;
HogenEsch, H ;
Suckow, M ;
Guimond, P ;
Martin, S ;
Borie, D ;
Torregrosa, S ;
Park, H ;
Park, K .
VACCINE, 1999, 17 (13-14) :1804-1811
[9]   INTERACTION OF ALGINATES AND PECTINS WITH CATIONIC POLYPEPTIDES [J].
BYSTRICKY, S ;
MALOVIKOVA, A ;
STICZAY, T .
CARBOHYDRATE POLYMERS, 1990, 13 (03) :283-294
[10]  
Cook PD, 1998, HANDB EXP PHARM, V131, P51